通化东宝：门冬胰岛素注射液获得境外药品注册证书

Core Insights - The company, Tonghua Dongbao, has received approval from the Indonesian Food and Drug Authority for the registration of its insulin aspart injection [1] Group 1 - The insulin aspart injection is a rapid-acting insulin analog that begins to take effect 10-20 minutes after subcutaneous injection [1] - The duration of action for the insulin aspart injection is 3-5 hours, primarily used for controlling postprandial blood glucose levels [1]